Adenosine potentiates human lung mast cell tissue plasminogen activator activity

Area of Science:

• Pulmonary Medicine
• Immunology
• Biochemistry

Background:

• Adenosine plays a key role in regulating pulmonary function.
• Mast cells are crucial immune cells involved in allergic responses and inflammation.
• Fibrinolysis, the breakdown of blood clots, is essential for maintaining vascular health.

Purpose of the Study:

• To investigate the effect of adenosine on the fibrinolytic activity of human lung mast cells (HLMC).
• To identify the specific adenosine receptors involved in this modulation.
• To determine the impact of adenosine on tissue plasminogen activator (tPA) activity and expression in HLMC.

Main Methods:

• Monitoring tPA activity and gene expression in HMC-1 cells and primary HLMC after adenosine treatment.
• Utilizing adenosine deaminase to confirm adenosine's role.
• Analyzing adenosine receptor expression profiles (A(2A), A(2B), A(3), A(1)).
• Employing pharmacological antagonists, including A(2A) receptor antagonist ZM241385.
• Assessing fibrin clot lysis in cell supernatants.

Main Results:

• Adenosine significantly potentiated HLMC tPA activity and gene expression in a dose-dependent manner.
• Adenosine-induced effects were reversed by adenosine deaminase.
• HLMC predominantly expressed A(2A) and A(2B) adenosine receptors.
• The A(2A) receptor was identified as the primary mediator of adenosine-induced tPA activity.
• Adenosine treatment increased fibrin clot lysis, an effect blocked by the A(2A) antagonist ZM241385.

Conclusions:

• Adenosine enhances mast cell fibrinolytic activity by upregulating tPA.
• The A(2A) adenosine receptor is the main subtype responsible for this effect.
• This study reveals a novel mechanism by which adenosine influences fibrinolysis in the context of lung inflammation.